FDA panel’s peptide loosening – hopeful or premature?

Posted by curious_scientist in Research & News - 2 points, 0 comments.

https://www.cbsnews.com/news/fda-peptides-review-regulations-unapproved-therapies

The CBS piece reports that an FDA advisory panel voted to ease restrictions on several peptides that were previously barred from compounding pharmacies. I’m cautiously optimistic because clearer guidelines could mean better quality control for those of us who rely on research-grade material, but I worry the move might open the door to more unverified claims hitting the market. From my own experience, inconsistent purity has caused unpredictable side effects, so any shift that pushes for tighter testing feels like a step forward. What do you think – will this actually improve safety, or just make it easier for shady vendors to sell “legal” peptides?

Community discussion - research and educational context only. Not medical advice.